Trials / Completed
CompletedNCT05015374
Effect of Astaxanthin on the Patients With Alzheimer Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study adapts a randomized, double-blind, placebo-controlled trial, to exam the possible benefit of Astaxanthin on Alzheimer disease. The enrolled Alzheimer patients will take Astaxanthin or placebo for 1 year. We will follow up Mini-Mental State Examination, Cognitive Ability Screening Instrument, Clinical Dementia Rating, and Neuropsychiatric Inventory at the end of the study.
Detailed description
This study aims to examine the benefit of Astaxanthin as adjuvant therapy for Alzheimer's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Astaxanthin | 350 mg/capsule (2mg Astaxanthin) |
| DIETARY_SUPPLEMENT | Placebo | Placebo |
Timeline
- Start date
- 2018-11-14
- Primary completion
- 2024-06-01
- Completion
- 2024-06-25
- First posted
- 2021-08-20
- Last updated
- 2024-09-27
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05015374. Inclusion in this directory is not an endorsement.